Tag : Lymphocyte

Gastroenterology

Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation

Newsemia
Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation Source link...
Latest News

KSQ Therapeutics Announces Discovery of Gene Targets with Potential Activity Superior to PD-1 for Development of Engineered Tumor Infiltrating Lymphocyte (eTIL™) Therapies for Solid Tumors

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically screen the whole genome to identify optimal gene targets for...
Latest News

Measles wipes out other immune memories

Newsemia
Thanks to misinformation and anti-vaccination campaigns in some pockets, United States and several nations of Europe have seen a massive outbreak of vaccine preventable measles...
Neurology

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

Newsemia
The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease...
Latest News

Customizing the Cellular Microenvironment to Improve Physiological Relevance

Newsemia
An interview with Marie-Charlotte Manus, discussing a new technology called PRIMO that improves the physiological relevance of cells in culture. Source link...
Neurology

Monitoring of Lymphocyte Populations During Treatment with Interferon-β-1b to Predict Multiple Sclerosis Disability Progression.

Newsemia
Monitoring of Lymphocyte Populations During Treatment with Interferon-β-1b to Predict Multiple Sclerosis Disability Progression. J Interferon Cytokine Res. 2018 Dec 28;: Authors: Vališ M, Vyšata...
Latest News

Lupin partners with Abbvie to develop and commercialize new targeted oncology treatments

Newsemia
Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1)...
Cardiology

Neutrophil to Lymphocyte Ratio as a Predictor of Outcomes after Amputation.

Newsemia
Related Articles Neutrophil to Lymphocyte Ratio as a Predictor of Outcomes after Amputation. Ann Vasc Surg. 2018 Oct 16;: Authors: Pierre-Louis WS, Bath J, Mikkilineni...
Pharma / Biotech

Meta-analysis of neutrophil-to-lymphocyte and platelet-to lymphocyte ratio in rheumatoid arthritis.

Newsemia
Related Articles Meta-analysis of neutrophil-to-lymphocyte and platelet-to lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest. 2018 Oct 13;:e13037 Authors: Erre GL, Paliogiannis P, Castagna...
Latest News

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Newsemia
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy